Navigation Links
New Hope For Patients With Relapsing Multiple Sclerosis

y Novartis Pharma and licensed from Mitsubishi Pharma Corporation.

Based on the positive results of the Phase II study conducted at 32 centers in 11 countries (Europe and Canada), Novartis is in discussions with regulatory authorities about the FTY720 Phase III program, which is expected to be launched by the end of 2005.
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:12/16/2009)... (Nasdaq: BLUD ), a global leader in providing ... announced that Paul D. Mintz, M.D. has been appointed ... January 1, 2010. ,, Dr. Mintz has been ... than 30 years. He is a tenured Professor of ... of Medicine. He also serves as director of the ...
(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...
(Date:12/16/2009)... led by the Wellcome Trust Sanger Institute announce the ... cancers are caused by mutations in the DNA of ... The studies, of a malignant melanoma and a lung ... mutations in the genomes of two cancers. , Lung ... almost all are associated with smoking. The number of ...
(Date:12/16/2009)... to Quality, Cost-Effective Care , ... Washington, D.C. (Vocus) ... the best ways to rein in runaway costs while providing care ... part of the ongoing discussion includes how to ensure patients equal ... of medicine (MDs) or osteopathy (DOs). In both the House ...
(Date:12/16/2009)... MassBio promote Massachusetts companies through annual marketing campaign , ... ... -- BioSpace unveiled the 2010 Genetown™ Hotbed Campaign ... , , ,Genetown is sponsored by MassBio and ... industries. The campaign places each entity’s brand on an ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Thriving Bioscience Region Leaves Its Mark 2
... neurological disorder in which misfiring electrical impulses in the ... epilepsy, and more than a million are female. //Pregnant ... that their children will have problems ranging from congenital ... to growing evidence that many commonly prescribed anti-epileptic drugs ...
... treatments may further increase the risk of breast and ... //Researchers offer new evidence that herbs such as red ... - as well as saw palmetto and rhodiola rosea ... could increase the risk of estrogen-related cancers. ...
... for long hours are more likely to be agitated.The ... and the New York State Psychiatric Institute. His team tracked ... found that those who had watched one or more hours ... into fights or behave aggressively towards other people later in ...
... According to a study, siblings of people with Alzheimer's ... of dementia.// More than half of patients with Alzheimer's ... This is an especially serious form of the condition, ... earlier need for institutional care. ,Researchers at ...
... Researchers say they've taken a major step toward cloning ... transplanted into humans. Such organs would save the lives ... transplants because of the shortage of human organs.// ... Dolly, scientists say they produced four piglets without one ...
... anxiety during pregnancy can increase a mother's risk of ... who were very anxious// in the last three months ... ,Lead researcher Professor Vivette Glover, of Imperial College, ... had extreme anxiety, and were frequently feeling scared.According ...
Other Medicine News:Health News: Pig cloning for organs, 2
(Date:12/16/2009)... -- Cohera Medical Inc. today announced the treatment ... its lead surgical adhesive product, TissuGlu®. Initiation of ... company,s progression of the lead product toward clinical ... prospective, open-label, randomized study to investigate the safety ... and associated complications in abdominoplasty, or "tummy tuck," ...
(Date:12/16/2009)... Dec. 16 CareCentrix, Inc ., ... management services, announced today that it has been ... DC-based health care accrediting organization that establishes quality ... guarantee that only appropriately trained, qualified clinical personnel ... a reasonable and timely appeals process is in ...
(Date:12/16/2009)... CHARLOTTESVILLE, Virginia, December 16 Biovista Inc.,today ... Innovator Presentation Award,in Healthcare, at the 2009 New ... MA. The award, which recognizes cutting edge private ... Biovista who competed with,over 50 other privately held ... the Technology, Life Sciences and Clean-tech sectors. , ...
Breaking Medicine Technology:First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3CareCentrix Receives URAC Health Utilization Management Accreditation 2Biovista Inc. Named Top Innovator in Life Sciences 2MapleWorks 26apos 3B Video Application Development Technology Allows for High Level of Collaboration Cooperation 58626 1MapleWorks 26apos 3B Video Application Development Technology Allows for High Level of Collaboration Cooperation 58626 2MapleWorks 26apos 3B Video Application Development Technology Allows for High Level of Collaboration Cooperation 58626 3Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 1ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 2ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 3ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 4
... from three studies,evaluating associations between lower mean baseline ... as well as the possible effect of,restrictions on ... the nation,s blood supply, will be presented at ... later this,month. The meeting will take place in ...
... Results demonstrating that TYKERB and trastuzumab together resulted,in ... -- Combining TYKERB and trastuzumab to attack ... may create a more complete HER2 blockade, ... patients,previous treatment with multiple lines of trastuzumab and ...
Other Medicine Technology:New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
... Knee design includes several innovative ... porous coating option for stable ... unique bone preserving posterior stabilizing ... to maximize range of motion, ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
Medicine Products: